Sugi Predict

Sugi Predict / Compounds / SCHEMBL990633

SCHEMBL990633

SCHEMBL990633

CC[N+](CC)(CC)Cc1ccccc1.[BH4-]

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ CYP1A2 P05177 1/20 0.49
▸ TP53 P04637 2/20 0.48
▸ CHRNA7 P36544 6/20 0.47
▸ CHRNB4 P30926 5/20 0.47
▸ CHRNA3 P32297 5/20 0.47
▸ DNM1 Q05193 2/20 0.44
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CHRNB2 P17787 3/20 0.42
▸ CHRNA4 P43681 3/20 0.42
▸ HTT P42858 2/20 0.41
▸ BCHE P06276 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Sulfide SCHEMBL5998579 0.97 KDM4E (0.54) KDM4EALDH1A1TDP1CYP1A2TP53
SCHEMBL81238 0.97 KDM4E (0.54) KDM4EALDH1A1TDP1CYP1A2TP53
Benzene SCHEMBL29130108 0.97 KDM4E (0.54) KDM4EALDH1A1TDP1CYP1A2TP53
Ammonia Solution, Strong SCHEMBL28017765 0.95 KDM4E (0.48) KDM4EALDH1A1TDP1CYP1A2TP53
Bromide SCHEMBL653934 0.95 KDM4E (0.52) KDM4EALDH1A1TDP1CYP1A2TP53
Bromide SCHEMBL117943 0.95 KDM4E (0.52) KDM4EALDH1A1TDP1CYP1A2TP53
Water SCHEMBL1973851 0.95 KDM4E (0.52) KDM4EALDH1A1TDP1CYP1A2TP53
Iodide SCHEMBL239644 0.95 KDM4E (0.52) KDM4EALDH1A1TDP1CYP1A2TP53
Hydrochloric Acid SCHEMBL7263491 0.95 KDM4E (0.58) KDM4EALDH1A1TDP1CYP1A2TP53
Hydrochloric Acid SCHEMBL80718 0.95 KDM4E (0.58) KDM4EALDH1A1TDP1CYP1A2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115215793-A Synthesis method of fluopyram 南开大学 2022-10-21 — — CN claimed
EP-3400313-A1 MULTI-PHENOTYPIC SUBTYPING OF BIOLOGICAL SAMPLES USING SEQUENTIAL FLUORESCENT QUENCHING AND RESTAINING Creatv Microtech, Inc. (US) 2018-11-14 — — EP claimed
US-20170199194-A1 MULTI-PHENOTYPIC SUBTYPING OF BIOLOGICAL SAMPLES USING SEQUENTIAL FLUORESCENT QUENCHING AND RESTAINING CREATV MICROTECH, INC. 2017-07-13 — — US claimed
WO-2017120553-A1 MULTI-PHENOTYPIC SUBTYPING OF BIOLOGICAL SAMPLES USING SEQUENTIAL FLUORESCENT QUENCHING AND RESTAINING CREATV MICRO TECH, INC. (US) 2017-07-13 — — WO claimed
EP-1555991-B1 AGENT AND METHOD FOR PERMANENTLY SHAPING HAIR, BASED ON ORGANIC BORON HYDRIDE DERIVATIVES WELLA AG (DE) 2006-12-06 — — EP claimed
US-20050214237-A1 Agent and method for permanent hair deformation based on organic borohysride derivatives WELLA AKTIENGESELLSCHAFT (DE) 2005-09-29 — — US claimed
CN-121172267-A Calcium iodide-based organic electrolyte, secondary battery and preparation method of secondary battery 新疆大学 2025-12-19 — — CN disclosed
US-20230226525-A1 PLATINUM-TUNGSTEN SOLID SOLUTION PARTICLES AND CATALYST CONTAINING SAME NIPPON SODA CO., LTD. (JP) 2023-07-20 — — US disclosed
EP-4169611-A1 PLATINUM-TUNGSTEN SOLID SOLUTION PARTICLES AND CATALYST CONTAINING SAME Nippon Soda Co., Ltd. (JP) 2023-04-26 — — EP disclosed
CN-115697552-A Platinum-tungsten solid solution particles and catalyst comprising same 日本曹达株式会社 2023-02-03 — — CN disclosed
CN-115215793-A Synthesis method of fluopyram 南开大学 2022-10-21 — — CN disclosed
EP-2905361-B1 METHOD OF FORMING A METAL COATING TOYOTA MOTOR CO LTD (JP) 2022-01-05 — — EP disclosed
WO-2021256061-A1 PLATINUM-TUNGSTEN SOLID SOLUTION PARTICLES AND CATALYST CONTAINING SAME 日本曹達株式会社 2021-12-23 — — WO disclosed
EP-1518018-A1 TREATMENT OF A MIXTURE CONTAINING CELLULOSE WITH A REDUCING AGENT BORREGAARD CHEMCELL (NO) 2005-03-30 — — EP disclosed
EP-1495017-A2 NOVEL HETEROARYL ALKYLAMIDE DERIVATIVES USEFUL AS BRADYKININ RECEPTOR MODULATORS Ortho-McNeil Pharmaceutical, Inc. (US) 2005-01-12 — — EP disclosed
US-20040192720-A1 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators ORTHO-MCNEIL PHARMACEUTICAL, INC. 2004-09-30 — — US disclosed
WO-2004003290-A1 TREATMENT OF A MIXTURE CONTAINING CELLULOSE WITH A REDUCING AGENT BORREGAARD CHEMCELL (NO) 2004-01-08 — — WO disclosed
US-20040000012-A1 Treatment of a mixture containing cellulose BORREGAARD CHEMCELL (NO) 2004-01-01 — — US disclosed
WO-2003087090-A2 NOVEL HETEROARYL ALKYLAMIDE DERIVATIVES USEFUL AS BRADYKININ RECEPTOR MODULATORS ORTHO-MCNEIL PHARMACEUTICAL,INC. (US) 2003-10-23 — — WO disclosed
US-6211196-B1 8-BENZYLOXY-(TETRAHYDRO)QUINOLINE DERIVATIVES; LIVER CIRRHOSIS, ALZHEIMER*S DISEASE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-04-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192720-A1 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators BDKRB2, BDKRB1, MRGPRX1 KDM4E 1624/4885ALDH1A1 4044/4885TDP1 4446/4885
US-20050214237-A1 Agent and method for permanent hair deformation based on organic borohysride derivatives KRT18, BTD, BRDT KDM4E 244/4885ALDH1A1 1768/4885TDP1 2563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.